Fig. 2From: Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidednessCirculating CTLs and Tregs in metastatic colorectal cancer patients in the context of primary tumor sidedness and KRAS mutation. p-values refer to the level of circulating T cell subsets in KRAS wt vs. KRAS mut in the entire study groupBack to article page